Literature DB >> 8013473

Propylene oxide mutagenesis at template cytosine residues.

E T Snow1, J Singh, K L Koenig, J J Solomon.   

Abstract

Propylene oxide (PO) is a widely used industrial reagent which is mutagenic and carcinogenic. We have recently shown that a variety of aliphatic epoxides, including propylene oxide, can react with DNA to form hydroxyalkyl adducts at N-3 of cytosine which rapidly undergo hydrolytic deamination to produce uracil adducts. These 3-hydroxyalkyl uracil adducts are stable in DNA and are postulated to be an important class of potentially mutagenic lesions. Mutagenesis at cytosine residues due to PO modification of single-stranded M13mp2/C141 DNA was studied by transfection of modified DNA into SOS and non-SOS induced E. coli host cells. Mutations of the proline (CCC) codon at C141 which result in reversion of the lacZ phenotype (blue plaques) were scored. It was found that PO treatment of single-stranded DNA results in dose-dependent mutagenesis that is highly SOS dependent. The spectrum of base-substitution mutations found at this site differed when PO-modified DNA was transfected into E. coli with different DNA repair backgrounds. These results indicate that propylene oxide induced DNA adducts at template cytosine residues are mutagenic in E. coli and that this mutagenesis is greatly increased by SOS processing. They also show that these lesions may be repaired by one or more mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013473     DOI: 10.1002/em.2850230403

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  2 in total

Review 1.  The role of mutagenic metal ions in mediating in vitro mispairing by alkylpyrimidines.

Authors:  O S Bhanot; J J Solomon
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

2.  Effects of chromium on DNA replication in vitro.

Authors:  E T Snow
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.